abstract |
The present invention relates to compounds of formula A and B and pharmaceutically acceptable salts: (A) and (B) [wherein A, B, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are as defined above]. The present invention further includes pharmaceutical compositions comprising a compound and a pharmaceutically acceptable salt, and diabetes mellitus and its complications, cancer, ischemia, inflammation, central nervous system disorders, cardiovascular disease, Alzheimer's disease and skin disease pressure, It relates to a method for treating viral diseases, inflammatory disorders or diseases where the liver is the target organ. [Chemical 1] |